TRENTON, N.J. — In a story Nov. 8 about a new drug approval, The Associated Press misspelled the drug's name. It is Prevymis, not Prevymix. A corrected version of the story is below: FDA OKs drug to block infection after marrow transplant U.S.
Read more >